With unfortunately no curative therapy for chronic spontaneous urticaria (CSU) available for now, the overall goal is to ...

Chronic spontaneous urticaria is an inflammatory skin disease that causes hives that last for at least six weeks. Derms ...

Earlier this month, Vice President and presidential nominee Kamala Harris released a report with details about her health and ...

If you're being treated for hives, your physician will want to hear what you think about your treatment. Is it working? Are your symptoms improving, staying the same, or getting worse? You may be ...

Emmeka Hawkins experienced itchy skin and bumps for over a year before she was diagnosed with chronic spontaneous urticaria.

While she tried everything she could to keep her skin healthy—moisturizing regularly and drinking plenty of water—Elisha ...

The anticipated data from the BEACON study, which evaluates briquilimab for chronic spontaneous urticaria, is a significant upcoming catalyst for Jasper Therapeutics. The study’s outcomes, expected in ...

In May 2024, Novartis announced new data that confirm the long-term efficacy and safety of remibrutinib, a highly selective ...

TD Cowen analyst Yaron Werber has maintained their bullish stance on JSPR stock, giving a Buy rating on October 29. Yaron Werber has given his ...

Opens in a new tab or window BOSTON -- Add-on dupilumab (Dupixent) significantly reduced itching and urticaria in patients with chronic spontaneous urticaria (CSU) whose symptoms were uncontrolled ...

Allakos shifted focus to AK006 in 2024 after lirentelimab's failure in phase 2 trials for atopic dermatitis and CSU. Read why ...

The biotech expects three Phase 2 readouts in urticaria and eczema over the next two years, and will keep its “options open” ...